pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS ≥1, hrHPV+ Oropharyngeal Cancer
Conditions:   Metastatic Oropharyngeal Carcinoma;   Recurrent Oropharyngeal Carcinoma Interventions:   Biological: DNA Vaccine;   Biological: Human Papillomavirus Tumor Antigen Vaccine;   Biological: Pembrolizumab;   Procedure: Computed Tomography (CT);   Procedure: Magnetic Resonance Imaging (MRI);   Procedure: Magnetic Resonance Imaging;   Procedure: Biopsy Sponsor:   Michael K. Gibson Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2023 Category: Research Source Type: clinical trials

Elimisha HPV (Human Papillomavirus)
Conditions:   Cervical Cancer;   HPV;   HIV;   Stigma Intervention:   Behavioral: Elimisha HPV Sponsors:   Duke University;   Fogarty International Center of the National Institute of Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials